Varhaug JE - Search Results

1

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy.

Aas T, Geisler S, Eide GE, Haugen DF, Varhaug JE, Bassøe AM, Thorsen T, Berntsen H, Børresen-Dale AL, Akslen LA, Lønning PE. Aas T, et al. Among authors: varhaug je. Eur J Cancer. 2003 Mar;39(4):438-46. doi: 10.1016/s0959-8049(02)00732-3. Eur J Cancer. 2003. PMID: 12751373

2

[Primary treatment of locally advanced breast cancer with neoadjuvant chemotherapy].

Aas T, Varhaug JE, Kolnes J, Søreide JA, Lønning PE. Aas T, et al. Among authors: varhaug je. Tidsskr Nor Laegeforen. 1994 Feb 28;114(6):668-70. Tidsskr Nor Laegeforen. 1994. PMID: 8191446 Norwegian.

3

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients.

Aas T, Børresen AL, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA, Lønning PE. Aas T, et al. Among authors: varhaug je. Nat Med. 1996 Jul;2(7):811-4. doi: 10.1038/nm0796-811. Nat Med. 1996. PMID: 8673929

4

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome.

Aas T, Geisler S, Paulsen T, Børresen-Dale AL, Varhaug JE, Lønning PE, Akslen LA. Aas T, et al. Among authors: varhaug je. Acta Oncol. 1996;35 Suppl 5:5-8. doi: 10.3109/02841869609083960. Acta Oncol. 1996. PMID: 9142957

5

Prognostic importance of various clinicopathological features in papillary thyroid carcinoma.

Akslen LA, Myking AO, Salvesen H, Varhaug JE. Akslen LA, et al. Among authors: varhaug je. Eur J Cancer. 1992;29A(1):44-51. doi: 10.1016/0959-8049(93)90574-y. Eur J Cancer. 1992. PMID: 1445745

6

Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.

Akslen LA, Varhaug JE. Akslen LA, et al. Among authors: varhaug je. Cancer. 1995 Nov 1;76(9):1643-54. doi: 10.1002/1097-0142(19951101)76:9<1643::aid-cncr2820760922>3.0.co;2-#. Cancer. 1995. PMID: 8635070

7

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer.

Paulsen T, Aas T, Børresen AL, Varhaug JE, Lønning PE, Akslen LA. Paulsen T, et al. Among authors: varhaug je. Int J Cancer. 1997 Feb 20;74(1):138-40. doi: 10.1002/(sici)1097-0215(19970220)74:1<138::aid-ijc23>3.0.co;2-a. Int J Cancer. 1997. PMID: 9036883 Free article. No abstract available.

8

Aggressive thyroid carcinoma with predominant cribriform growth pattern. Case report.

Akslen LA, Maehle BO, Varhaug JE. Akslen LA, et al. Among authors: varhaug je. Pathol Res Pract. 1996 Nov;192(11):1129-33; discussion 1134. doi: 10.1016/S0344-0338(96)80030-6. Pathol Res Pract. 1996. PMID: 9122032

9

Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas.

Fluge O, Akslen LA, Haugen DR, Varhaug JE, Lillehaug JR. Fluge O, et al. Among authors: varhaug je. Int J Cancer. 2000 Sep 15;87(6):763-70. doi: 10.1002/1097-0215(20000915)87:6<763::aid-ijc1>3.0.co;2-t. Int J Cancer. 2000. PMID: 10956383 Free article.

10

RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer.

Knappskog S, Myklebust LM, Busch C, Aloysius T, Varhaug JE, Lønning PE, Lillehaug JR, Pendino F. Knappskog S, et al. Among authors: varhaug je. Ann Oncol. 2011 Oct;22(10):2208-15. doi: 10.1093/annonc/mdq737. Epub 2011 Feb 16. Ann Oncol. 2011. PMID: 21325450 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page